Evidence map›Paper›PMID 40673680›Full record

ArticlemBio2025

A core human gut microbe,

Gabrielle Mingolelli, Jessia Raherisoanjato, Duong Trinh, Yu Gao, Matthew Henke

Abstract read
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Bacteriocins fromFrontiers in microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gabrielle MingolelliDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA.ORCID 0009-0004-6061-2444
Jessia RaherisoanjatoDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA.
Duong TrinhDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA.
Yu GaoDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA.
Matthew HenkeDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA.ORCID 0000-0001-8325-6420

Funding

Research Training in Natural Product Complementary and Integrative HealthT32AT007533 · NCCIH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Joanna E Burdette, JIMMY ORJALA · 2013 to 2026
$4.3M
Highly sensitive proteomics method to probe cell heterogeneity at single cell resolutionR35GM133416 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Yu Gao · 2019 to 2026
$2.4M
NCCIH NIH HHS T-32AT007533NCCIH NIH HHS T32 AT007533NIGMS NIH HHS R35 GM133416NIH HHS R35-GM133416University of Illinois at Chicago start-up funds
6 · The paper itself

Abstract

A diverse, stable community of microbes in the human gut is strongly tied to health. The factors that regulate microbial community structure and dynamics are ill-defined. In this study, we discover mediterrocin, a bacteriocin produced by the core member of the human gut microbiota, IMPORTANCE:

Indexed as

Anti-Bacterial AgentsBacteriocinsEubacterialesGastrointestinal MicrobiomeRuminococcusHumansMicrobial Sensitivity TestsMultigene FamilyAnti-Bacterial AgentsBacteriocinsbacteriocingut microbiomeMediterraneibacter gnavus

Identifiers

PMID40673680
PMCPMC12345188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.